This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hospi Corporation Enhances Board Of Directors With Two New Appointments

NEWARK, Calif., April 17, 2014 /PRNewswire/ -- Hospi Corporation, a privately-held medical device company, has appointed to its board of directors John Freidenrich and Richard (Dick) Kashnow, two highly respected and experienced investors.

"We are delighted that John and Dick have joined our board at this important juncture as we launch our first commercial product," said Igal Ladabaum, chief executive officer of Hospi Corporation.  "With the recent FDA approval of the Macy Catheter™, we are making strong progress towards establishing Hospi as an innovator of practical, patient-centric medical devices.  John and Dick will both provide wise and relevant input to our plans for Hospi's growth.  We also greatly appreciate their personal investments in the company that, together with other investors' contributions to our recent Series A financing, support the commercial launch of the Macy Catheter."

John Freidenrich received his bachelor's degree and LLD from Stanford University and began his career as a lawyer, founding the law firm of Ware & Freidenrich in 1968.  Now part of DLA Piper, it continues to be one of Silicon Valley's preeminent law firms. Mr. Freidenrich founded the venture capital firm Bay Partners in 1976 and led the firm for over a quarter century. Currently, he is a founding partner of Regis Management Company, LLC, an independent private investment firm that partners with families, foundations, and endowments.  A former Chairman of the Stanford University Board of Trustees, he has also been a long time Director of Stanford Hospital and Clinics.

Richard Kashnow is the former chairman and chief executive of Raychem. He started his career as a physicist at General Electric's R&D Center.  Later he held technical and general management positions in several GE businesses.  Following Tyco's acquisition of Raychem, he formed a venture capital unit for Tyco and led investments in communications and medical device companies.  He has served on the boards of several public and private technology companies.  He is currently a director of Electronics for Imaging (Nasdaq:EFII).  He served as an officer in the U.S. Army.  He holds a PhD in physics from Tufts University and a BS in physics from Worcester Polytechnic Institute. 

About the Macy Catheter The Macy Catheter is the only device designed and approved solely for the ongoing rectal delivery of medications and liquids.  It was invented by 20-year veteran hospice nurse, Brad Macy, RN, BSN, CHPN, co-founder of Hospi and recipient of the 2013 National Hospice and Palliative Care Nurse of the Year Award.  The device offers clinicians and caregivers an easy, discreet and comfortable alternative to rectal administration of medication, and is particularly useful for patients with serious or terminal illness who often lose the ability to swallow.

About Hospi CorporationHospi Corporation is a privately-held medical device company that improves quality of life by innovating practical, high-impact medical devices that enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.  The company's patient-centric focus, which is informed by a nursing perspective, guided the development of its first product, the Macy Catheter™.  Hospi Corporation has received Small Business Innovation Research (SBIR) grants from the National Science Foundation and the NIH's National Institute of Nursing Research to support development of its products.  For more information, visit

SOURCE Hospi Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs